Karen Malateste
- Virology top 5%
- HIV Research and Treatment 7
- Infectious Diseases top 5%
- HIV/AIDS Research and Interventions 23
- HIV/AIDS drug development and treatment 9
- Emergency Medicine top 10%
- HIV-related health complications and treatments 10
- Safety Research top 10%
- General Health Professions top 10%
- Adolescent Sexual and Reproductive Health 4
-
- Pneumocystis jirovecii pneumonia detection and treatment 7
- HIV, Drug Use, Sexual Risk 5
-
- Global Maternal and Child Health 4
- Co-authors
- Valériane LeroyFatoumata DickoFrançois DabisMary‐Ann DaviesAzar KariminiaKara Wools‐KaloustianDidier Koumavi EkouéviSamuel Ayaya
- Partner nations
- FranceIvory CoastUnited States
In The Last Decade
Karen Malateste
25 papers receiving 385 citations
Peers
Comparison fields: 5 of 47
- Virology 132
- Infectious Diseases 350
- Emergency Medicine 86
- Safety Research 47
- General Health Professions 96
Countries citing papers authored by Karen Malateste
This map shows the geographic impact of Karen Malateste's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karen Malateste with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karen Malateste more than expected).
Fields of papers citing papers by Karen Malateste
This network shows the impact of papers produced by Karen Malateste. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karen Malateste. The network helps show where Karen Malateste may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Karen Malateste, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 3 | |
| 3 | 2023 | 0 | |
| 4 | 2022 | 3 | |
| 5 | 2021 | 5 | |
| 6 | 2020 | 57 | |
| 7 | 2020 | 2 | |
| 8 | 2019 | 7 | |
| 9 | 2018 | 23 | |
| 10 | 2018 | 11 | |
| 11 | 2017 | 13 | |
| 12 | 2017 | 2 | |
| 13 | 2015 | 15 | |
| 14 | 2015 | 6 | |
| 15 | 2014 | 3 | |
| 16 | 2013 | 19 | |
| 17 | 2011 | 49 | |
| 18 | 2011 | 8 | |
| 19 | 2010 | 10 | |
| 20 | 2010 | 11 |
About Karen Malateste
Karen Malateste is a scholar working on Virology, Infectious Diseases and Emergency Medicine, having authored 27 papers that have together received 391 indexed citations. Recurring topics across this work include HIV/AIDS Research and Interventions (23 papers), HIV-related health complications and treatments (10 papers), HIV/AIDS drug development and treatment (9 papers), HIV Research and Treatment (7 papers), Pneumocystis jirovecii pneumonia detection and treatment (7 papers), HIV, Drug Use, Sexual Risk (5 papers), Global Maternal and Child Health (4 papers) and Adolescent Sexual and Reproductive Health (4 papers). The work is most often cited by research in Virology (132 citations), Infectious Diseases (350 citations) and Emergency Medicine (86 citations). Karen Malateste has collaborated with scholars based in France, Ivory Coast and United States. Frequent co-authors include Valériane Leroy, Fatoumata Dicko, François Dabis, Mary‐Ann Davies, Azar Kariminia, Kara Wools‐Kaloustian, Didier Koumavi Ekouévi, Samuel Ayaya, Lorna Renner and Constantin T. Yiannoutsos. Their work appears in journals such as PLoS ONE, Antimicrobial Agents and Chemotherapy and PLoS Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.